Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
1.910
+0.030 (1.60%)
At close: Mar 9, 2026, 4:00 PM EDT
1.950
+0.040 (2.09%)
After-hours: Mar 9, 2026, 4:26 PM EDT
CELZ Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 7 | 4 | 6 | 5 | 14 | 17 | |
| Market Cap Growth | -36.93% | -36.61% | 18.77% | -61.64% | -16.41% | 2018.13% | |
| Enterprise Value | 1 | -2 | -6 | -17 | 14 | 18 | |
| Last Close Price | 1.88 | 2.31 | 4.61 | 3.81 | 22.10 | 139.00 | |
| PE Ratio | - | - | - | - | 0.73 | - | |
| PS Ratio | 1095.00 | 367.17 | 707.96 | 60.55 | 159.35 | 101.69 | |
| PB Ratio | 0.87 | 0.64 | 0.62 | 0.34 | 1.37 | -0.42 | |
| P/TBV Ratio | 1.27 | 0.70 | 0.64 | 0.35 | 1.44 | - | |
| EV/Sales Ratio | 201.44 | - | - | - | 163.74 | 107.06 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | |
| Net Debt / Equity Ratio | -0.96 | -0.93 | -0.96 | -1.16 | -1.05 | -0.02 | |
| Net Debt / EBITDA Ratio | 0.90 | 1.05 | 1.81 | 1.81 | 3.53 | -0.67 | |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.26 | |
| Inventory Turnover | 1.09 | 1.00 | 0.43 | 2.71 | - | - | |
| Quick Ratio | 20.57 | 18.13 | 26.89 | 5.54 | 10.21 | 0.00 | |
| Current Ratio | 20.71 | 18.73 | 27.66 | 5.64 | 10.22 | 0.00 | |
| Return on Equity (ROE) | -98.14% | -65.85% | -40.34% | -77.78% | - | - | |
| Return on Assets (ROA) | -59.68% | -41.30% | -23.49% | -42.05% | -32.60% | -111.61% | |
| Return on Capital Employed (ROCE) | -108.80% | -90.60% | -54.30% | -64.60% | -30.60% | 2.80% | |
| Earnings Yield | -90.74% | -136.01% | -82.97% | -189.10% | 137.39% | -217.15% | |
| Buyback Yield / Dilution | -52.66% | -5.17% | -28.76% | -236.51% | -460.63% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.